May 28, 2017 11:12 PM ET


Company Overview of Celgene Cellular Therapeutics, Inc.

Company Overview

Celgene Cellular Therapeutics, Inc. engages in the research, recovery culture-expansion, preservation, development, and distribution of placental cells. The company develops placental cells, including stem and progenitor cells as therapeutic agents. It discovers and develops therapeutics from cells derived from the human placenta, as well as from the umbilical cord. The company develops stem cells for therapeutic applications in cancer, as well as autoimmune, cardiovascular, neurological, and degenerative diseases. It also operates a private umbilical cord blood bank. The company was formerly known as Anthrogenesis Corp. and changed its name to Celgene Cellular Therapeutics, Inc. in 2002. Ce...

7 Powder Horn Drive

Warren, NJ 07059-5190

United States





Key Executives for Celgene Cellular Therapeutics, Inc.

Celgene Cellular Therapeutics, Inc. does not have any Key Executives recorded.

Celgene Cellular Therapeutics, Inc. Key Developments

Perry Karsen to Retire as CEO of Celgene Cellular Therapeutics, Inc. at the End of 2015

Perry Karsen, Chief Executive Officer of Celgene Cellular Therapeutics (CCT), is retiring at the end of 2015.

Celgene Cellular Therapeutics Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-07-2015 09:15 AM

Celgene Cellular Therapeutics Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-07-2015 09:15 AM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Perry Karsen, CEO.

BioCision, LLC to Develop Customized ThawSTAR Automated Cell Thawing System for Celgene Cellular Therapeutics

BioCision, LLC announced that it will collaborate with Celgene Cellular Therapeutics (CCT) to accelerate the development of a cell thawing solution based on BioCision's proprietary ThawSTAR™ technology for the 6 mL injectable vial that CCT has chosen to store PDA-002, a cryopreserved, allogeneic cell therapy currently in clinical development to treat diabetic foot ulcers in patients with peripheral arterial disease. Conventional thawing methods, including swirling vials in warm water baths or rolling vials between hands can result in variable cell viabilities and can increase contamination concerns. BioCision’s ThawSTAR system utilizes a patent pending adaptive sensing technology that incorporates algorithms to deliver a consistent and reproducible thaw profile and endpoint to each vial, thus providing a standardized thawing process, eliminating variability that could have a detrimental effect on the safety and efficacy of the cell therapy, and providing a significant reduction in cell handling risk in a clinical setting. The new ThawSTAR automated cell thawing system that will be developed as a result of this collaboration is an expansion of BioCision’s technology platform and will be made available commercially. BioCision is also developing other vial formats to address the needs of the larger cell therapy market.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celgene Cellular Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at